Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease.
Epoxyeicotrienoic acids (EETs) are cytochrome P450-dependent anti-hypertensive and anti-inflammatory derivatives of arachidonic acid, which are highly abundant in the kidney and considered reno-protective. EETs are degraded by the enzyme soluble epoxide hydrolase (sEH) and sEH inhibitors are conside...
Main Authors: | Oliver Jung, Felix Jansen, Anja Mieth, Eduardo Barbosa-Sicard, Rainer U Pliquett, Andrea Babelova, Christophe Morisseau, Sung H Hwang, Cindy Tsai, Bruce D Hammock, Liliana Schaefer, Gerd Geisslinger, Kerstin Amann, Ralf P Brandes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-08-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2915917?pdf=render |
Similar Items
-
Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
by: Sean D. Kodani, et al.
Published: (2018-10-01) -
Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
by: John D. Imig, et al.
Published: (2020-09-01) -
Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
by: Cindy B. McReynolds, et al.
Published: (2019-05-01) -
Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation
by: Brandes Ralf P, et al.
Published: (2011-10-01) -
Effects of soluble epoxide hydrolase deficiency on acute pancreatitis in mice.
by: Ahmed Bettaieb, et al.
Published: (2014-01-01)